Literature DB >> 19231786

Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?

Hani Mawardi1, Nathaniel Treister, Paul Richardson, Kenneth Anderson, Nikhil Munshi, Robert A Faiella, Sook-Bin Woo.   

Abstract

PURPOSE: Bisphosphonate-associated osteonecrosis of the jaw (BONJ) is defined as the presence of exposed bone for at least 8 weeks in patients with exposure to bisphosphonates and no history of radiotherapy to the jaw. We report 5 patients with a history of bisphosphonate use, sinus tracts or deep periodontal pockets and radiographic findings typical for BONJ but with no evidence of exposed necrotic bone at the first evaluation visit. PATIENTS AND METHODS: The mean age was 70 years (range 66-77) and all were males. Patients had multiple myeloma (2), multiple myeloma and prostate cancer (1), monoclonal gammopathy of unknown significance (1) and osteoporosis (1). Three cases involved the mandible and 2 the maxilla. Four patients were on intravenous pamidronate and/or zoledonic acid and 1, alendronate. All cases except 1 (with deep periodontal pockets) presented with intraoral draining sinus tracts.
RESULTS: Radiographic findings included persistence of extraction socket (2), mottled radio-opacity and radiolucency (1), presence of sequestrum (1) and no significant findings (1). Subsequently, 4 patients developed exposed bone and 1 patient had necrotic bone removed from the jaws.
CONCLUSION: We report 5 patients with a history of bisphosphonate therapy where 4 patients had persistent sinus tracts and a fifth, severe bone loss. Four patients had radiographic findings typical for BONJ, and all subsequently developed necrotic bone. We propose modifying the definition of BONJ to include a category of "suspected BONJ" Stage 0(sa) where patients have persistent sinus tracts or localized deep periodontal pockets and typical radiographic findings for BONJ but are asymptomatic, and Stage 0(ss) for those who are symptomatic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231786     DOI: 10.1016/j.joms.2008.09.031

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  27 in total

Review 1.  A systematic review of bisphosphonate osteonecrosis (BON) in cancer.

Authors:  Cesar Augusto Migliorati; Sook-Bin Woo; Ian Hewson; Andrei Barasch; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-04-22       Impact factor: 3.603

Review 2.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

3.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

Review 4.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

Review 5.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

6.  Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?

Authors:  Belir Atalay; Serhat Yalcin; Yusuf Emes; Irem Aktas; Buket Aybar; Halim Issever; Nil Molinas Mandel; Ozge Cetin; Bora Oncu
Journal:  Lasers Med Sci       Date:  2011-08-02       Impact factor: 3.161

Review 7.  Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review.

Authors:  Paul de Boissieu; L Kanagaratnam; R Mahmoudi; A Morel; M Dramé; T Trenque
Journal:  Eur J Clin Pharmacol       Date:  2017-02-10       Impact factor: 2.953

8.  Radiographic predictors of bone exposure in patients with stage 0 medication-related osteonecrosis of the jaws.

Authors:  Akrivoula Soundia; Danny Hadaya; Sanjay M Mallya; Tara L Aghaloo; Sotirios Tetradis
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2018-08-29

9.  Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?

Authors:  Hiroaki Shimamoto; Tristan R Grogan; Tomomi Tsujimoto; Naoya Kakimoto; Shumei Murakami; David Elashoff; Tara L Aghaloo; Sotirios Tetradis
Journal:  Dentomaxillofac Radiol       Date:  2017-12-15       Impact factor: 2.419

10.  A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw.

Authors:  H Mawardi; G Giro; M Kajiya; K Ohta; S Almazrooa; E Alshwaimi; S-B Woo; I Nishimura; T Kawai
Journal:  J Dent Res       Date:  2011-09-15       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.